November 6, 2017

Analysts Rating Alert: Evolent Health, Inc. (NYSE:EVH), Attunity Ltd. (NASDAQ:ATTU), Hologic, Inc. (NASDAQ:HOLX)

Evolent Health, Inc. (NYSE:EVH)’s stock on Friday traded at beginning with a price of $ and when day-trade ended the stock finally moved down -11.07% to reach at $13.25. Analyst’s mean target price for EVH is $30.36 while analysts mean recommendation is 1.50. Stock value has moved between $14.4 – 27.6 in last one year.

Analyst’s ratings play a very important role in outlining a stock’s performance. Let us check out how analysts have ranked EVH based on current scenarios. Stock has got OUTPERFORM rating from 6 analyst(s) whereas last month 5 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 7 analyst(s) given BUY rating to the stock. Company fiscal year is ending in December and analysts’ consensus recommendation is Buy for EVH and estimated EPS for next quarter is $ -0.05 .

Evolent Health, Inc. (NYSE:EVH) yearly performance is -31.17% and net profit margin is -49.20%. The current share price indicates that stock is -51.82% away from its one year high and is moving -8.30% ahead of its 52-week low.

On 03 November 2017, Attunity Ltd. (NASDAQ:ATTU) stock price started the day at $ and moved between $ to finally close at $8.05. ATTU’s distance from 20 day simple moving average is 15.85% and distance from 50-Day simple moving average is 18.38%. In last 4 months performance of ATTU was 25.39% while its price to sale ratio is 2.33 and price to book ratio is 4.50.

Analysts expect Attunity Ltd. (NASDAQ:ATTU) to report $ 0.11 EPS and has got OUTPERFORM rating from 2 of Thomson Reuters analysts and 0 analyst(s) given UNDERPERFORM rating. Analyst’s mean target price for ATTU is $11.17 while analysts mean recommendation is 1.70. Firm LT growth rate is estimated as 20.00 %.

Hologic, Inc. (NASDAQ:HOLX)’s stock on Friday traded at beginning with a price of $ and when day-trade ended the stock finally moved up 2.97% to reach at $39.56. Analyst’s mean target price for HOLX is $47.43 while analysts mean recommendation is 1.90. Stock value has moved between $35.64 – 46.54 in last one year.

Stock has got OUTPERFORM rating from 6 analyst(s) whereas last month 6 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 8 analyst(s) given BUY rating to the stock. Company fiscal year is ending in September and analysts’ consensus recommendation is Outperform for HOLX and estimated EPS for next quarter is $ 0.49 .

Hologic, Inc. (NASDAQ:HOLX) yearly performance is 6.37% and net profit margin is 25.60%. Annual EPS Growth of past 5 years is 14.20%. The current share price indicates that stock is -15.47% away from its one year high and is moving 10.63% ahead of its 52-week low.

Leave a Reply

Your email address will not be published. Required fields are marked *